Scott Boyle
Vermogen: 471 108 $ op 31-05-2026
Vermogen: 471 108 $ op 31-05-2026
Scott N.
Boyle is currently the Chief Business Officer at C4 Therapeutics, Inc., a position held since 2022.
Education history includes an undergraduate degree from Brigham Young University, a doctorate from Yale University, and an MBA from Harvard Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2026 | 107.805 ( 0,1% ) | 471 108 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau